COVID-19 Windfall Will Help Pfizer Remain Top Drug Company
Pfizer splits earnings on the vaccine evenly with BioNTech
Pfizer said it expects its COVID-19 vaccine to generate $15bn in 2021, but the forecast appears to be an underestimation as it includes only contracted doses.